PMID:19875284: Difference between revisions
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php |
imported>Wikientrybot change PMID template to TableEdit version |
||
| Line 1: | Line 1: | ||
{{RightTOC}} | {{RightTOC}} | ||
< | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.166669.L5223907fd87cf--> | ||
< | <!-- | ||
****************************************************************************************** | |||
* | |||
* ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | |||
* | |||
****************************************************************************************** --> | |||
{| id="L5223907fd87cf" class=" tableEdit PMID_info_table" | |||
|- | |- | ||
| | !align=left |Citation | ||
|| | |||
'''No author listed''' (2009) Discovery and optimization of antibacterial AccC inhibitors. ''Bioorg. Med. Chem. Lett.'' '''19''':6507-14 | |||
|- | |- | ||
| | !align=left |Abstract | ||
|| | |||
The biotin carboxylase (AccC) is part of the multi-component bacterial acetyl coenzyme-A carboxylase (ACCase) and is essential for pathogen survival. We describe herein the affinity optimization of an initial hit to give 2-(2-chlorobenzylamino)-1-(cyclohexylmethyl)-1H-benzo[d]imidazole-5-carboxamide (1), which was identified using our proprietary Automated Ligand Identification System (ALIS).(1) The X-ray co-crystal structure of 1 was solved and revealed several key interactions and opportunities for further optimization in the ATP site of AccC. Structure Based Drug Design (SBDD) and parallel synthetic approaches resulted in a novel series of AccC inhibitors, exemplified by (R)-2-(2-chlorobenzylamino)-1-(2,3-dihydro-1H-inden-1-yl)-1H-imidazo[4,5-b]pyridine-5-carboxamide (40). This compound is a potent and selective inhibitor of bacterial AccC with an IC(50) of 20 nM and a MIC of 0.8 microg/mL against a sensitized strain of Escherichia coli (HS294 E. coli). | |||
|- | |||
!align=left |Links | |||
|| | |||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19875284 PubMed] | |||
Online version:[http://dx.doi.org/10.1016/j.bmcl.2009.10.057 10.1016/j.bmcl.2009.10.057] | |||
|- | |||
!align=left |Keywords | |||
|| | |||
Anti-Bacterial Agents/chemical synthesis; Anti-Bacterial Agents/chemistry; Anti-Bacterial Agents/pharmacology; Benzimidazoles/chemical synthesis; Benzimidazoles/chemistry; Benzimidazoles/pharmacology; Carbon-Nitrogen Ligases/antagonists & inhibitors; Crystallography, X-Ray; Drug Discovery; Enzyme Inhibitors/chemical synthesis; Enzyme Inhibitors/chemistry; Enzyme Inhibitors/pharmacology; Escherichia coli/drug effects; Imidazoles/chemical synthesis; Imidazoles/chemistry; Imidazoles/pharmacology; Ligands; Microbial Sensitivity Tests; Models, Molecular; Nicotinic Acids/chemical synthesis; Nicotinic Acids/chemistry; Nicotinic Acids/pharmacology; Structure-Activity Relationship | |||
|- class="tableEdit_footer" | |||
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.166669.L5223907fd87cf&page=166669&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> || | |||
|} | |} | ||
< | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.166669.L5223907fd87cf--> | ||
==Significance {{HelpIcon|Help:Literature}} == | ==Significance {{HelpIcon|Help:Literature}} == | ||
{{LitSignificance}} | {{LitSignificance}} | ||
Revision as of 19:07, 1 September 2013
| Citation |
No author listed (2009) Discovery and optimization of antibacterial AccC inhibitors. Bioorg. Med. Chem. Lett. 19:6507-14 |
|---|---|
| Abstract |
The biotin carboxylase (AccC) is part of the multi-component bacterial acetyl coenzyme-A carboxylase (ACCase) and is essential for pathogen survival. We describe herein the affinity optimization of an initial hit to give 2-(2-chlorobenzylamino)-1-(cyclohexylmethyl)-1H-benzo[d]imidazole-5-carboxamide (1), which was identified using our proprietary Automated Ligand Identification System (ALIS).(1) The X-ray co-crystal structure of 1 was solved and revealed several key interactions and opportunities for further optimization in the ATP site of AccC. Structure Based Drug Design (SBDD) and parallel synthetic approaches resulted in a novel series of AccC inhibitors, exemplified by (R)-2-(2-chlorobenzylamino)-1-(2,3-dihydro-1H-inden-1-yl)-1H-imidazo[4,5-b]pyridine-5-carboxamide (40). This compound is a potent and selective inhibitor of bacterial AccC with an IC(50) of 20 nM and a MIC of 0.8 microg/mL against a sensitized strain of Escherichia coli (HS294 E. coli). |
| Links |
PubMed Online version:10.1016/j.bmcl.2009.10.057 |
| Keywords |
Anti-Bacterial Agents/chemical synthesis; Anti-Bacterial Agents/chemistry; Anti-Bacterial Agents/pharmacology; Benzimidazoles/chemical synthesis; Benzimidazoles/chemistry; Benzimidazoles/pharmacology; Carbon-Nitrogen Ligases/antagonists & inhibitors; Crystallography, X-Ray; Drug Discovery; Enzyme Inhibitors/chemical synthesis; Enzyme Inhibitors/chemistry; Enzyme Inhibitors/pharmacology; Escherichia coli/drug effects; Imidazoles/chemical synthesis; Imidazoles/chemistry; Imidazoles/pharmacology; Ligands; Microbial Sensitivity Tests; Models, Molecular; Nicotinic Acids/chemical synthesis; Nicotinic Acids/chemistry; Nicotinic Acids/pharmacology; Structure-Activity Relationship |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
See also
References
See Help:References for how to manage references in EcoliWiki.